New exciting treatment options currently being trialed could change the way the disease is treated long term.Read More »
By Stanley S. Schwartz, MD and Mary E Herman, PhD
Despite guidelines, hypoglycemia can largely be avoided without shortchanging tight glucose control.
Screening, treatment delay may hasten or increase cardiovascular disease risk.Read More »
Man, 52 years of age, with obesity and type 2 diabetes, was switched from daily liraglutide (Victoza) 1.8mg to weekly semaglutide (Ozempic) 0.25mg. I was very clear with patient about the switch being from a daily injection to a weekly and that we would be increasing the semaglutide weekly.Read More »
Prospective study evaluates use of nasal glucagon for treatment of moderate to severe hypoglycemia in adults with type 2 diabetes.Read More »
Study finds higher hospital admissions, complications, and mortality rates among patients with increased A1c.Read More »
Guest Post by David Kliff, Editor, Diabetic Investor
Senseonics has taken their Eversense implantable CGM before an FDA panel, and Bigfoot has announced they have closed their series B $55 million financing round. The FDA has approved Dexcom’s G6 system, pushing shares in the company higher in early trading. And while they didn’t announce anything recently, our friends at Tandem are feeling the love as shares continue to surge higher in anticipation of their new system, which has low glucose suspend.
Knowing the drugs that can affect blood glucose levels is essential in properly caring for your diabetes patients. Some medicines raise blood sugar in patients while others might lower their levels. However, not all drugs affect patients the same way. The list includes: Drugs that may cause hyperglycemia Drugs that may cause hypoglycemia Drugs that may cause hyper or hypoglycemia Drugs that mask hypoglycemiaRead More »
Organization says adults with type 2 diabetes can aim for an easier-to-achieve blood sugar target than what’s been used to guide treatment in the past.Read More »
When added to statin therapy in patients with diabetes, ezetimibe provides greater cardiovascular protection than what is seen in individuals without diabetes.Read More »